For about as long as I’ve been writing The Niche, people have been asking about stem cells for MS. There’s a huge need for new therapies. While a chemo-based approach with autologous hematopoietic stem cell transplantation (HSCT) looks to work for certain cases of multiple sclerosis (although not yet approved in the US), other cell …
Weekly reads: stem cells for MS, good news x2, extending dog years, Neuralink updates Read More »
The post Weekly reads: stem cells for MS, good news x2, extending dog years, Neuralink updates appeared first on The Niche.